Efficacy of dupilumab in atopic comorbidities associated with moderate-to-severe adult atopic dermatitis.

Eustachio NettisVincenzo PatellaCarla LombardoAikaterini DetorakiLuigi MacchiaElisabetta Di LeoMonica CarbonaraGiorgio W CanonicaLaura Bonzano

Published in: Allergy (2020)

These results support the benefits of dupilumab for adult patients with PAR and/or PAA associated with msAD.

Keyphrases